@jontoledo.bsky.social
📤 29
📥 45
📝 14
Significant milestone for the Dementia with Lewy Bodies community: new DLB trials moving to Phase 3; CervoMed aligned with the FDA on a registration path for neflamapimod.
#Dementia
#LewyBodyDementia
#DLB
#ClinicalTrials
#Phase3
#Neflamapimod
30 days ago
0
0
0
@alzassociation.bsky.social
critically support research to fulfill their mission of a world without Alzheimer's through: • SEEDING new ideas • SPEEDING development of new therapies • SCALING Over $450M+ funding across 56 countries, increasing their support for early-career researchers.
about 1 month ago
0
0
0
Empowering the care team makes a difference in
#dementia
. @Alz_Journals: InDePendent trial found that tailored care by qualified nurses provided for people living with dementia led to 74% fewer unmet needs and higher quality of life, cost-effectively
#dementiacare
#careteam
about 1 month ago
0
0
0
Texas Proposition 14, a game-changer to fight Alzheimer’s and other dementias.
#TXProp14
would fund the Dementia Prevention and Research Institute of Texas (DPRIT) with a $3 billion investment from the state's budget surplus. Vote YES
#AlzheimersResearch
#TexasElections
#DPRIT
www.alz.org/yeson14
about 1 month ago
0
0
0
Representing
#LBDA
and
@houstonmethodist.bsky.social
at the
#HAPS
Engage.Educate.Empower. Symposium
3 months ago
0
0
0
Proud to be designated an LBDA Research Center of Excellence. This placard represents our commitment to patients and families we serve, and our dedication to advancing a cure. A huge thank you to our dedicated team and the entire LBD community.
#LewyBodyDementia
#DementiaResearch
#LBDA
#EndLBD
4 months ago
1
4
0
reposted by
JAMA
9 months ago
When they become eligible for Medicare, beneficiaries must choose to enroll in Medicare Advantage (MA) or traditional Medicare. This Viewpoint discusses the differences between MA and traditional Medicare.
https://ja.ma/3FzVLc0
0
21
9
Exciting work form Borghammer's lab describing sympathetic and parasympathetic involvement and brain vs body first progression in
#LBD
#PD
#DLB
further read in
bit.ly/41N13Z2
9 months ago
0
2
2
SHIMMER COG1201
#CT1812
showed in mid-moderate
#DLB
phase 2 exploratory positive results in NPI caregiver burden, underpowered results favoring cognitive CDR, ADL, MDS-UPDRS III for CT1812
10 months ago
0
1
0
Well deserved rising star awards
#ILBDC
#DLB
10 months ago
0
3
0
Broad expertise panel discussion in
#DLB
#Staging
including
#ATN
#NSD-ISS
#SynNeurGe
and @LBDAssoc
10 months ago
0
1
0
Ian McKeith was just surprised with the announcement and being awarded the first DLB lifetime award at
#ILBDC
#DLB
10 months ago
0
2
0
reposted by
The Lewy Body Society
10 months ago
Thank you to
@rorycj.bsky.social
for his support on World Lewy Body Day!
#dementia
add a skeleton here at some point
0
2
1
reposted by
The Lewy Body Society
10 months ago
Looking forward to World Lewy Body Day tomorrow! Thank you to ITN Business for sharing this on the eve of our big day. Please help us tomorrow by sharing our posts to try to get the world to understand that dementia doesn't always mean Alzheimer's.
#worldlewybodyday
#wlbd2025
#lewybodydementia
loading . . .
World Lewy Body Dementia Day 2025: Shining a spotlight on the “unknown” dementia - ITN Business
This Sunday 28th January marks the first World Lewy Body Day, a new awareness day that aims to shine a light on Lewy body dementia (LBD).
https://business.itn.co.uk/new-world-awareness-day-is-launched-for-lewy-body-dementia/
0
5
5
Feeling like a late and quiet Christmas day on the way to work in Houston.
11 months ago
0
2
0
See our new paper on the impact of Lewy and Alzheimer co-pathology on cognitive and clinical changes
#DLBAwareness
#Alzheimers
#EndDementia
#CoPathologies
bit.ly/3DU8WDT
loading . . .
Cognitive decline profiles associated with lewy pathology in the context of Alzheimer’s disease neuropathologic change - Alzheimer's Research & Therapy
Background Alzheimer’s disease neuropathologic change (ADNC) and Lewy pathology (LP) often coexist in cognitively impaired individuals. These pathologies’ relative distribution and severity may modify...
https://bit.ly/3DU8WDT
11 months ago
0
4
1
IMPACT AD; training program for professionals interested in Alzheimer's clinical trials. Overview of all clinical trials aspects, proposals reviews, career advice, and mentoring. Join the program and become an alumni.
#IMPACT_AD
#Alzheimers
#ClinicalTrials
impact-ad.org
11 months ago
0
1
0
you reached the end!!
feeds!
log in